You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Low Molecular Weight Heparin Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
The global Low Molecular Weight Heparin market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Low Molecular Weight Heparin by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Low Molecular Weight Heparin Industry
Figure Low Molecular Weight Heparin Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Low Molecular Weight Heparin
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Low Molecular Weight Heparin
1.2.2 Downstream
Table Application Segment of Low Molecular Weight Heparin
Table Global Low Molecular Weight Heparin Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Low Molecular Weight Heparin Market by Type
3.1 By Type
3.1.1 Enoxaparin
Table Major Company List of Enoxaparin
3.1.2 Dalteparin
Table Major Company List of Dalteparin
3.1.3 Tinzaparin
Table Major Company List of Tinzaparin
3.1.4 Fraxiparine
Table Major Company List of Fraxiparine
3.2 Market Size
Table Global Low Molecular Weight Heparin Market 2016-2020, by Type, in USD Million
Figure Global Low Molecular Weight Heparin Market Growth 2016-2020, by Type, in USD Million
Table Global Low Molecular Weight Heparin Market 2016-2020, by Type, in Volume
Figure Global Low Molecular Weight Heparin Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Low Molecular Weight Heparin Market Forecast 2021-2026, by Type, in USD Million
Table Global Low Molecular Weight Heparin Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Aspen (Company Profile, Sales Data etc.)
4.1.1 Aspen Profile
Table Aspen Overview List
4.1.2 Aspen Products & Services
4.1.3 Aspen Business Operation Conditions
Table Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sanofi-aventis (Company Profile, Sales Data etc.)
4.2.1 Sanofi-aventis Profile
Table Sanofi-aventis Overview List
4.2.2 Sanofi-aventis Products & Services
4.2.3 Sanofi-aventis Business Operation Conditions
Table Business Operation of Sanofi-aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer (Company Profile, Sales Data etc.)
4.3.1 Pfizer Profile
Table Pfizer Overview List
4.3.2 Pfizer Products & Services
4.3.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Opocrin (Company Profile, Sales Data etc.)
4.4.1 Opocrin Profile
Table Opocrin Overview List
4.4.2 Opocrin Products & Services
4.4.3 Opocrin Business Operation Conditions
Table Business Operation of Opocrin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 CSBIO (Company Profile, Sales Data etc.)
4.5.1 CSBIO Profile
Table CSBIO Overview List
4.5.2 CSBIO Products & Services
4.5.3 CSBIO Business Operation Conditions
Table Business Operation of CSBIO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dongying Tiandong Pharmaceutical (Company Profile, Sales Data etc.)
4.6.1 Dongying Tiandong Pharmaceutical Profile
Table Dongying Tiandong Pharmaceutical Overview List
4.6.2 Dongying Tiandong Pharmaceutical Products & Services
4.6.3 Dongying Tiandong Pharmaceutical Business Operation Conditions
Table Business Operation of Dongying Tiandong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Changzhou Qianhong Bio-pharma (Company Profile, Sales Data etc.)
4.7.1 Changzhou Qianhong Bio-pharma Profile
Table Changzhou Qianhong Bio-pharma Overview List
4.7.2 Changzhou Qianhong Bio-pharma Products & Services
4.7.3 Changzhou Qianhong Bio-pharma Business Operation Conditions
Table Business Operation of Changzhou Qianhong Bio-pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Techdow (Company Profile, Sales Data etc.)
4.8.1 Techdow Profile
Table Techdow Overview List
4.8.2 Techdow Products & Services
4.8.3 Techdow Business Operation Conditions
Table Business Operation of Techdow (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Yantai Dongcheng Pharmaceutical Group (Company Profile, Sales Data etc.)
4.9.1 Yantai Dongcheng Pharmaceutical Group Profile
Table Yantai Dongcheng Pharmaceutical Group Overview List
4.9.2 Yantai Dongcheng Pharmaceutical Group Products & Services
4.9.3 Yantai Dongcheng Pharmaceutical Group Business Operation Conditions
Table Business Operation of Yantai Dongcheng Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Low Molecular Weight Heparin Sales Revenue 2016-2020, by Company, in USD Million
Table Global Low Molecular Weight Heparin Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Low Molecular Weight Heparin Sales Revenue Share in 2020, by Company, in USD Million
Table Global Low Molecular Weight Heparin Sales Volume 2016-2020, by Company, in Volume
Table Global Low Molecular Weight Heparin Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Low Molecular Weight Heparin Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Low Molecular Weight Heparin Market Concentration, in 2020
Figure Europe Low Molecular Weight Heparin Market Market Concentration, in 2020
Figure Asia-Pacific Low Molecular Weight Heparin MMarket Concentration, in 2020
Figure South America Low Molecular Weight Heparin Market Concentration, in 2020
Figure Middle East & Africa Low Molecular Weight Heparin Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Treatment of Venous Thromboembolism
Figure Low Molecular Weight Heparin Demand in Treatment of Venous Thromboembolism, 2016-2020, in USD Million
Figure Low Molecular Weight Heparin Demand in Treatment of Venous Thromboembolism, 2016-2020, in Volume
6.1.2 Demand in Complications of Pregnancy
Figure Low Molecular Weight Heparin Demand in Complications of Pregnancy, 2016-2020, in USD Million
Figure Low Molecular Weight Heparin Demand in Complications of Pregnancy, 2016-2020, in Volume
6.1.3 Demand in Cardioversion of Atrial Fibrillation/Flutter
Figure Low Molecular Weight Heparin Demand in Cardioversion of Atrial Fibrillation/Flutter, 2016-2020, in USD Million
Figure Low Molecular Weight Heparin Demand in Cardioversion of Atrial Fibrillation/Flutter, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Low Molecular Weight Heparin Demand in Others, 2016-2020, in USD Million
Figure Low Molecular Weight Heparin Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Low Molecular Weight Heparin Demand Forecast 2021-2026, by Application, in USD Million
Figure Low Molecular Weight Heparin Market Growth 2021-2026, by Application, in USD Million
Figure Low Molecular Weight Heparin Market Share in 2026, by Application, in USD Million
Table Low Molecular Weight Heparin Demand Forecast 2021-2026, by Application, in Volume
Table Low Molecular Weight Heparin Market Growth 2021-2026, by Application, in Volume
Table Low Molecular Weight Heparin Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Low Molecular Weight Heparin Production 2016-2020, by Region, in USD Million
Table Low Molecular Weight Heparin Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Low Molecular Weight Heparin Market 2016-2020, by Region, in USD Million
Table Global Low Molecular Weight Heparin Market Share 2016-2020, by Region, in USD Million
Table Global Low Molecular Weight Heparin Market 2016-2020, by Region, in Volume
Table Global Low Molecular Weight Heparin Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Low Molecular Weight Heparin Market Size and Growth 2016-2020, in USD Million
Figure North America Low Molecular Weight Heparin Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Low Molecular Weight Heparin Market Size 2016-2020, by Country, in USD Million
Table North America Low Molecular Weight Heparin Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Low Molecular Weight Heparin Market Size and Growth 2016-2020, in USD Million
Figure Europe Low Molecular Weight Heparin Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Low Molecular Weight Heparin Market Size 2016-2020, by Country, in USD Million
Table Europe Low Molecular Weight Heparin Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Low Molecular Weight Heparin Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Low Molecular Weight Heparin Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Low Molecular Weight Heparin Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Low Molecular Weight Heparin Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Low Molecular Weight Heparin Market Size and Growth 2016-2020, in USD Million
Figure South America Low Molecular Weight Heparin Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Low Molecular Weight Heparin Market Size 2016-2020, by Country, in USD Million
Table South America Low Molecular Weight Heparin Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Low Molecular Weight Heparin Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Low Molecular Weight Heparin Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Low Molecular Weight Heparin Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Low Molecular Weight Heparin Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Low Molecular Weight Heparin Market Forecast 2021-2026, by Region, in USD Million
Table Low Molecular Weight Heparin Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44236